Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Tyme Technologies Inc (TYME)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Tyme Tech's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Tyme Tech historical data, for real-time data please try another search
0.3107 +0.0000    +0.00%
16/09 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.2850 - 0.3150
Tyme Tech 0.3107 +0.0000 +0.00%

Tyme Technologies Inc Company Profile

 
Get an in-depth profile of Tyme Technologies Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

13

Equity Type

ORD

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey. As of September 16, 2022, Tyme Technologies, Inc. operates as a subsidiary of Syros Pharmaceuticals, Inc.

Contact Information

Address 1 Pluckemin Way Suite 103
Bedminster, 07921
United States
Phone 212 461 2315
Fax -
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TYME Comments

Write your thoughts about Tyme Technologies Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
grafitx esposito
grafitx esposito Jan 18, 2022 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GM has signed a long-term agreement with MP Materials for the supply of rare-earth materials, alloys and finished magnets used in the electric motors that are powering its growing number of electric vehicles.mp buy buy target price 62 73 98
Sudhakar Ks
Sudhakar Ks Jul 26, 2021 2:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sudhakars
Alec Confy
Alec Confy May 13, 2021 9:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
new CFOmerger with Swiss multinational ??
Victor Alvarez
Victor Alvarez Apr 28, 2021 2:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice consolidation around 1.5 and it seems now is starting to show a bullish pattern, so it may be a good time to buy now
Alec Confy
Alec Confy Apr 27, 2021 6:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy now the ascent has begun; I also recommend txmd and jagxscience sector will be green for a long time
Victor Alvarez
Victor Alvarez Apr 20, 2021 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any recent news? They had several tests near the FDA approval but nothing has been released yet right?
Maurice Gibson
Maurice Gibson Apr 20, 2021 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nothing since 4/1/21. TYME19 got patent approval but with vaccines going out to everyone they may be too late to the party to capitalize on Tyme 19
Victor Alvarez
Victor Alvarez Apr 20, 2021 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
true about the covid treatment... so until they get success/approval for any of the cancer treatments like SM-88 then we may not see a rebound...
Beny Muler
Beny Muler Apr 20, 2021 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when is the date or any road map of sm88?
Victor Alvarez
Victor Alvarez Apr 20, 2021 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In the Tyme company page they have a picture whre they say they are in Phase III... that it seems to be the last phase. Not sure what does this represent in timelines.... https://www.tymeinc.com/our-science/pipeline/default.aspx
Maurice Gibson
Maurice Gibson Apr 12, 2021 12:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Looks like EPS will hit expectations in June of -.06 per share. They are still burning through capital and burned all the offering $ at $2:50. They are going to need a breakthrough or approval very soon.
Igor Ruban
Igor Ruban Apr 08, 2021 1:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dump this junk buy crypto instead
Motor Show
Motor Show Apr 08, 2021 1:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
He lllyMu, geHb7u JIlO69lT TullluHy
Maurice Gibson
Maurice Gibson Feb 25, 2021 1:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We are betting on a company that needs FDA approval and that doesn't happen over night!  Hang tight until next quarter and buy on the drawbacks...
ez tenim
ez tenim Feb 24, 2021 5:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how long this basura is gonna go down
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email